Cargando…
Napsin A as a marker of clear cell ovarian carcinoma
BACKGROUND: Clear cell carcinomas are aggressive tumors with a distinct biologic behaviour. In a genome-wide screening for genes involved in chemo-resistance, NAPA was over-expressed in cisplatin-resistant cells. The NAPA (protein) Napsin A was described to promote resistance to cisplatin by degrada...
Autores principales: | Skirnisdottir, Ingiridur, Bjersand, Kathrine, Åkerud, Helena, Seidal, Tomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228360/ https://www.ncbi.nlm.nih.gov/pubmed/24191930 http://dx.doi.org/10.1186/1471-2407-13-524 |
Ejemplares similares
-
The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancer
por: Bjersand, Kathrine, et al.
Publicado: (2017) -
Differences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma
por: Skirnisdottir, Ingiridur, et al.
Publicado: (2015) -
The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I–II
por: SKIRNISDOTTIR, INGIRIDUR, et al.
Publicado: (2016) -
Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease
por: Skirnisdottir, Ingiridur, et al.
Publicado: (2012) -
Napsin-A Expression, a Reliable Immunohistochemical Marker for Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas
por: Nili, Fatemeh, et al.
Publicado: (2020)